Health News

Cimzia Linked to Life-Threatening Cancer Risk Among Children, Childish Adults

Cimzia Linked to Life-Threatening Cancer Risk Among Children, Boyish Adults
Cimzia (certolizumab pegol) is an autoimmune chaos narcotic belonging to a family of drugs familiar as tumour necrosis fixin's (TNF) inhibitors. Recently, Cimzia, along with distinct other TNF blockers, were linked to an increased risk of cancer among patients captivating the drug, specifically among early adults and children.
The U.S. Cookery and Drug Governance (FDA) launched an examination into the TNF blockers after at least 30 cases of cancer among children consuming the drugs were reported during a ten-year margin from 1998 to 2008, according to a Sept 2008 story article from Reuters.
TNF Blockers Under Investigation
TNF inhibitors were inceptive approved by the FDA in 1998. A tome declared as "Arthritis Without Pain" that was published in 2000 and revised in 2004, describes TNF inhibitors as a "miracle" drug, and that no certified contrary side baggage or symptoms existed, however, this "miracle" impression was recently challenged by the FDA"s findings that the Cimzia may effect cancer. Of the TNF blockers under issue are those that are used to treat autoimmune disorders and include:
* Remicade (infliximab)
* Humira (adalimumab)
* Enbrel (etanercept)
* Cimzia (certolizumab pegol)
According to the Mayo Clinic, TNF blockers are most repeatedly associated with the treatment of rheumatoid arthritis, in which the "wear and tear on joints" causes inflammation within the bones and joints. Almost 2 million individuals in America suffer from the arthritic context and it is most commonly institute in women rather than in men. Extra TNF blocker side stuff include:
* headache
* fever
* nausea
* chills
* myalgia
What is Cimzia?
Cimzia is used specifically to treat Crohn"s disease a example in which the digestive tract becomes inflamed and adversely affects the gastrointestinal (GI) tract, according to the Civic Digestive Diseases Info Clearinghouse (NDDIC).
Further Cimzia Side Effects
In appendix to the deadpan risk associated with developing cancer while consuming Cimzia, the drug again contains other many side item that may beginning severe damage to an individual"s health, according to an article in the Atlanta Journal-Constitution (AJC). Cimzia side part include:
* headache
* diarrhea
* fever
* abdominal paint
* upper respiratory infection
* nausea
* reactions to the injection area
Cimzia was approved in Apr 2008 for applicability on the bazaar by the FDA and while results from a clinical research published in The Different Great britain Almanac of Medicine, the drug is already growth investigated for the abeyant risk of cancer as great as the risk of developing life-threatening infections.
Pharmaceutical Legal Assistance
Patients who keep taken Cimzia or any of the fresh TNF blockers and those who may be at risk for the imaginable Cimzia-induced cancer risk should seek medical keeping immediately. Any type of cancer that can be caught early testament viable aftereffect in a greater outcome than one that is not detected until it has modern to untreatable stages.
08 Jan 2009 05:25:27

UCB: Cimzia's indication expansion hindered by FDA - Pharmaceutical Business Review

UCB: Cimzia's indication expansion hindered by FDA Pharmaceutical Business Review - By James Wentworth UCB has received a complete response letter from the FDA in relation to Cimzia (certolizumab) in the treatment of rheumatoid arthritis, ...
06 Jan 2009 05:05:57

UCB stock down as FDA asks for more Cimzia data - Pharma Times

UCB stock down as FDA asks for more Cimzia data Pharma Times, UK - The US Food and Drug Administration has issued a complete response letter relating to the Biologics License Application for Cimzia (certolizumab pegol) ... UCB's Cimzia receives complete response letter for rheumatoid ... STOCKS NEWS EUROPE-UCB shares fall on US drug delay UCB falls sharply on Cimzia setback
06 Jan 2009 00:41:25

French and Benelux stocks - Factors to watch on Jan 6 - Forbes

French and Benelux stocks - Factors to watch on Jan 6 Forbes, NY - The Belgian pharmaceutical group says the US Food and Drug Administration (FDA) had requested a new safety update on its Cimzia drug in rheumatoid arthritis ...
06 Jan 2009 00:11:54

Think Twice Before You Pop That Pill - theTrumpet.com

Think Twice Before You Pop That Pill theTrumpet.com, OK - In addition, the entire class of arthritic medications such as Remicade, Enbrel, Humira and Cimzia were linked to the development of lymphoma and other ...
05 Jan 2009 14:19:50

Thriving in 2008: Approvals, Deals and Other Silver Linings - TMCnet

Thriving in 2008: Approvals, Deals and Other Silver Linings TMCnet - 27), UCB SA's Cimzia (certolizumab pegol, April 22) and Amgen Inc.'s Nplate (romiplostim, Aug. 22). The FDA's Center for Biologics Evaluation and Research ...
05 Jan 2009 11:42:12

BRIEF-UCB says FDA wants new safety update on Cimzia in rheumatoid ... - Interactive Investor

BRIEF-UCB says FDA wants new safety update on Cimzia in rheumatoid ... Interactive Investor, UK - Interactive Investor Trading Limited, trading as "Interactive Investor", is authorised and regulated by the Financial Services Authority. ...
05 Jan 2009 08:06:21

XOMA Appoints Fred Kurland as Chief Financial Officer - Reuters

XOMA Appoints Fred Kurland as Chief Financial Officer Reuters - ... plaque psoriasis, LUCENTIS(r) (ranibizumab injection) for wet age-related macular degeneration and CIMZIA (r) (certolizumab pegol) for Crohn's disease. ...

Keywords:

cimzia, cimzia linked, adults cimzia, cimzia certolizumab, cimzia fresh, cimzia headache, cimzia drug, cimzia approved, cimzia effects, cimzia effect
Health News © John Davis 2008